Ceftobiprole medocaril sodium is a Cephalosporin Antibiotic for Infection Research
On April 4, 2024, the U.S. Food and Drug Administration recently approved ceftobiprole medocaril sodium, a medication with a wide range of applications in bacterial infections. Ceftobiprole medocaril sodium is…